Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy
Study Information
Alliance Study ID: NCCTG-979253
NCT Study ID (ClinicalTrials.gov): NCT00003600
Disease or Cancer Type: Other Cancer
Alliance Study Chair: Thomas E. Witzig, MD
Status: COMPLETED
Study Description
RATIONALE: Epoetin alfa may stimulate red blood cell production and treat anemia in patients with cancer who are receiving chemotherapy. It is not yet known whether epoetin alfa is more effective than a placebo in treating anemia in patients receiving chemotherapy.
PURPOSE: Randomized double blinded phase III trial to compare the effectiveness of epoetin alfa with a placebo in treating anemia in cancer patients who are receiving chemotherapy.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information